Form 4 for BDTX Black Diamond Therapeutics, Inc.
Accepted 2023-07-07 00:00:00 ET · period of report 2023-07-05 · accession 0001104659-23-079144 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-07-07 | 2023-07-05 | BDTX | RA CAPITAL MANAGEMENT, L.P. | Dir | P - Purchase | $5.00 | +935.9K | 3.21M | +41% | +$4.68M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-05 | P | A | 935,850 | $5.00 | 3,213,828 | I See Footnotes | — | — | (F1) Acquired from the Issuer pursuant to the public offering described in the Issuer's Prospectus filed with the Securities and Exchange Commission on June 30, 2023. (F2) Held directly by RA Capital Healthcare Fund, L.P. (the "Fund"). (F3) RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and RA Capital Nexus Fund, L.P. (the "Nexus Fund"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein. |